Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Researchers develop diagnostic tool to examine traveling cancer cells, improve health outcomes

Researchers develop diagnostic tool to examine traveling cancer cells, improve health outcomes

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

UCLA research could lead to simple saliva test for early diagnosis of deadly diseases

UCLA research could lead to simple saliva test for early diagnosis of deadly diseases

Simple blood test may help spot pancreatic cancer

Simple blood test may help spot pancreatic cancer

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

New automaton model simulates various scenarios of tumor growth

New automaton model simulates various scenarios of tumor growth

New research may help identify individuals at increased risk of pancreatic cancer

New research may help identify individuals at increased risk of pancreatic cancer

Recent clinical study sheds light on potential approach to more personalized care for pancreatic cancer

Recent clinical study sheds light on potential approach to more personalized care for pancreatic cancer

Scientists show how BRCA2 protein works to repair damaged DNA

Scientists show how BRCA2 protein works to repair damaged DNA

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Scientists discover sign of early development of pancreatic cancer

Scientists discover sign of early development of pancreatic cancer

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Disrupting cancer regulator MYC: an interview with Professor Kim Janda

Disrupting cancer regulator MYC: an interview with Professor Kim Janda

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

KIT spinoff amcure develops tumor therapeutic agents to reduce mortality rate

KIT spinoff amcure develops tumor therapeutic agents to reduce mortality rate

State highlights: Calif. hospital accused of patient dumping; Wash. mental health changes

State highlights: Calif. hospital accused of patient dumping; Wash. mental health changes

Study links gum disease to lung disease, cancer and heart failure

Study links gum disease to lung disease, cancer and heart failure

Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.